71463-36-0 Usage
Uses
Used in Pharmaceutical Industry:
[1R-(1alpha,4abeta,4balpha,10aalpha)]-1,2,3,4,4a,4b,5,6,10,10a-decahydro-7-isopropyl-1,4a-dimethylphenanthren-1-methylamine hydrochloride is used as a potential pharmaceutical compound for its possible pharmacological or biological activity. Its structural similarity to other phenanthrene compounds and the presence of the amine functional group make it a candidate for further research and development in the pharmaceutical field.
Used in Chemical Research:
In the field of chemical research, [1R-(1alpha,4abeta,4balpha,10aalpha)]-1,2,3,4,4a,4b,5,6,10,10a-decahydro-7-isopropyl-1,4a-dimethylphenanthren-1-methylamine hydrochloride can be used as a subject for studying the effects of stereochemistry on the properties and reactivity of complex organic molecules. Its unique structure may provide insights into the behavior of similar compounds and contribute to the advancement of chemical knowledge.
Used in Material Science:
[1R-(1alpha,4abeta,4balpha,10aalpha)]-1,2,3,4,4a,4b,5,6,10,10a-decahydro-7-isopropyl-1,4a-dimethylphenanthren-1-methylamine hydrochloride's complex molecular structure and specific stereochemistry may also make it a candidate for material science applications, where it could be investigated for potential uses in the development of new materials with specific properties, such as optoelectronic or sensor applications.
Check Digit Verification of cas no
The CAS Registry Mumber 71463-36-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,4,6 and 3 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 71463-36:
(7*7)+(6*1)+(5*4)+(4*6)+(3*3)+(2*3)+(1*6)=120
120 % 10 = 0
So 71463-36-0 is a valid CAS Registry Number.
71463-36-0Relevant academic research and scientific papers
Compositions and methods relating to proliferative diseases
-
, (2017/02/24)
Anti-cancer compositions and methods are described herein. In particular, compositions including one or more of leelamine, a leelamine derivative, abietylamine, an abietylamine derivative, and an abietic acid derivative are described. Methods for treatmen
